Xeris Pharmaceuticals Lands $565,000 New Funding Round

  • Feed Type
  • Date
    7/11/2013
  • Company Name
    Xeris Pharmaceuticals
  • Mailing Address
    3925 West Braker Lane 3rd Floor Austin, TX 78759
  • Company Description
    Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.
  • Website
    http://www.xerispharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $565,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.